Association Between COVID-19 and Severity of Illness for Children With Hyperglycemic Crisis
Vanessa Toomey, Margret J. Klein, Alaina P. Vidmar, Lily C. Chao, Jose Pineda, Anoopindar Bhalla- Pediatrics
- General Medicine
- Pediatrics, Perinatology and Child Health
OBJECTIVES
Admissions to the ICU for children with hyperglycemic crisis (HGC, defined as diabetic ketoacidosis, hyperglycemic hyperosmolar syndrome, or hyperosmolar ketoacidosis) increased during the COVID-19 pandemic. We sought to identify if severity of illness for HGC also increased from prepandemic to pandemic years 1 and 2.
METHODS
Retrospective study of children aged ≤18 years hospitalized in the Pediatric Health Information System for HGC. Pre-COVID-19 years were defined as March 2017–February 2020, COVID-19 year 1 as March 2020–February 2021, and COVID-19 year 2 as March 2021–February 2022. The primary outcome was ICU admission. Secondary outcomes included mortality, length of stay, cost, and use of neurologic therapies, mechanical ventilation, or vasoactive support.
RESULTS
There were 46 425 HGC admissions to 42 hospitals, 20 045 (43.2%) of which were ICU admissions. In comparison with pre-COVID-19, children admitted in COVID-19 year 1 (odds ratio, 1.31 [95% confidence interval, 1.25–1.38], P < .0001) and year 2 (odds ratio, 1.17 [95% confidence interval, 1.11–1.22], P < .0001) had a higher odds of ICU admission in multivariable modeling after controlling for confounding variables. Severity of illness was higher during COVID-19 years when considering secondary outcomes, although these associations were not consistent across outcomes and year. There was no difference in mortality.
CONCLUSIONS
Children with HGC had a higher severity of illness during the pandemic which was sustained over 2 years. Reduction in social distancing and evolving variants of SARS-CoV-2 over the 2 years of the pandemic did not significantly alter the relationship between HGC and higher requirement for ICU care.